Disruptive change in contemporary medical education
Here, L. Maximilian Buja, MD, describes a disruptive change in contemporary medical education and explains the unintended consequences of that change.
COVID-19 and Africa’s volatile changing epidemics landscape
Here, SACIDS Foundation for One Health discuss the volatile changing epidemics landscape in Africa.
Mental health in times of the pandemic
Here, Pfalzklinikum discusses the pertinent issue of mental health in the times of the pandemic.
Bridging the gap between clinical trials and clinical care
Here, Tatiana Affini Dicenzo and Freimut Schliess discuss bridging the gap between clinical trials and clinical care, specifically exploring if wearables are fit for this purpose.
Air pollution and brain health
Here, Professor Pamela J. Lein and Professor Anthony S. Wexler of Neurotoxicology discuss the crucial issue of air pollution and brain health.
Contaminants and infections: A link to explore
Here, Alberto Mantovani of the Endocrine Disruptors Project here discusses what there is to learn from the recent COVID-19 pandemic.
How to create and deliver an online lecture: A survival guide during pandemic times
Professor Darren Griffin, University of Kent, and Dr Julia Stephenson, Brunel University London, discuss how to create and deliver an online lecture during these pandemic times
Can cannabidiol treat Type 2 diabetes?
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
Digitisation and Healthcare in the UK
Here, Fujitsu discuss the plan for changing current situation of digitisation and healthcare in the UK.
Post-hospital discharge care for dementia patients
Here, the Department of Medicine & Therapeutics discuss the programmes that are supporting post-hospital care for Dementia patients.
Mental health and illness in the public mirror
Magdalena Rosset, Miriam Jaspersen, Anja Dittrich, Eva Baumann and Paul Bomke share their research findings on how mental health and illness is reflected in journalism.
Global Obesity: A ticking time bomb
Here, Professor Barry M. Popkin and colleagues at the University of North Carolina (UNC) examine research on global obesity.
Are plasticizing chemicals contributing to the worldwide epidemic of obesity?
Here, UC Davis focus on the prevalence of Bisphenol A (BPA) and further explore how this plasticizing chemical can be contributing to the worldwide epidemic of obesity.
Elixinol: The benefits of cannabidiol (CBD)
Here, we learn more about the company’s (Elixinol) offering of cultivating top-quality strains of hemp, 100% organically grown and naturally processed to exceed industry standards.
A focus on cardiovascular sciences: Vital research in the field
The excellent work of Policlinico Universitario A Gemelli is explored here when it comes to vital research in the field of cardiovascular sciences.
Cannabinoid supplements and medicines
Here, GreenLight Medicines tell us what they do and the excellent supplements and medicines they offer in connection with cannabinoids and health. We also learn about their excellent research and development of safe and effective plant-based medicines.
Vitamin D and pregnancy – understanding the beneficial effects
Vitamin D, an essential fat-soluble vitamin and steroid hormone, is explored here with a focus on its beneficial effects when it comes to pregnancy.
Colorectal cancer: Towards precision medicine
In this detailed analysis, Jérôme Galon and Daniela Bruni at INSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, in France, discuss colorectal cancer.
Multidomain interventions: How to prevent dementia in Hong Kong
Here, Professor Timothy Kwok, Director of Jockey Club Centre for Positive Ageing, details multi-domain interventions to prevent dementia in Hong Kong, underlining important areas such as primary prevention, healthy diet, physical exercise and mild cognitive impairment.
A special focus on diabetic retinopathy
Dr Lalit Pukhrambam at Wayne State University School of Medicine is researching how to find a cure for the blinding eye disease of diabetic retinopathy by targeting a protein called thioredoxin-interacting protein (TXNIP), as we find out here.